Clinical Trials in Granada, Andalucia

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

NCT ID: NCT05109728

This clinical trial is investigating a new treatment called [177Lu]Lu-DOTA-TATE for patients with glioblastoma, a type of brain cancer. The study aims to find the best dose of this treatment when u...

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

NCT ID: NCT05939414

This clinical trial is studying a new treatment called lutetium (177Lu) vipivotide tetraxetan for men with oligometastatic prostate cancer (OMPC), which means their cancer has spread to a few place...

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

NCT ID: NCT06407934

This clinical trial is designed to evaluate how well two different doses of a medication called amlitelimab work for people aged 12 years and older with moderate-to-severe atopic dermatitis, a cond...

Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

NCT ID: NCT07013760

This clinical trial is looking to understand how effective a medication called tezepelumab is in treating patients with severe asthma in Spain. The study will gather information from patients who h...

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

NCT ID: NCT05976243

This clinical trial is studying a medication called remibrutinib to see if it helps adults with a condition known as Chronic Inducible Urticaria (CINDU), which causes sudden skin reactions like hiv...

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

NCT ID: NCT06042478

This clinical trial is studying a new medication called remibrutinib for adults with chronic spontaneous urticaria (CSU), a condition that causes itchy hives. The trial will compare remibrutinib to...

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

NCT ID: NCT06724159

The SOGUG-PRINCIS clinical trial is studying how effective certain new drugs are for treating genitourinary cancers, such as those affecting the kidney, bladder, or prostate. This is an observation...

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

NCT ID: NCT05849298

This clinical trial is studying a new treatment called AAA617, both on its own and combined with another therapy, for men with a specific type of prostate cancer known as castration-resistant prost...

Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

NCT ID: NCT06997458

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

NCT ID: NCT05739942

This clinical trial is studying a new treatment called [177Lu]Lu-NeoB for people with glioblastoma, a type of brain cancer. It aims to find the safest and most effective dose of this treatment when...

PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin

NCT ID: NCT05810870

The SABINA clinical trial is studying a new treatment approach for patients with advanced or metastatic breast cancer that has specific genetic alterations (PIK3CA or PTEN alterations). The trial i...

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

NCT ID: NCT06004661

This clinical trial is studying a treatment called lutetium (177Lu) vipivotide tetraxetan for men with a type of prostate cancer known as metastatic castration-resistant prostate cancer (mCRPC). Th...

Spanish Series of Patients Treated With the Radionuclide Lutetium177

NCT ID: NCT04949282

This clinical trial is studying the use of a treatment called Lutetium-177-DOTATATE, which is used for patients with certain types of tumors, including neuroendocrine tumors and other related cance...